Web Results

Aprepitant

en.wikipedia.org/wiki/Aprepitant

Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the ...

EMEND® (aprepitant) 80 mg, 125 mg capsules EMEND ...

www.emend.com/

The Merck Access Program can help answer your questions about: insurance coverage for patients, benefit investigations, prior authorizations, appeals, and ...

Aprepitant: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/aprepitant.html

Easy to read patient leaflet for aprepitant. Includes indications, proper use, special instructions, precautions, and possible side effects.

APREPITANT - ORAL (Emend) side effects, medical uses, and drug ...

www.medicinenet.com/aprepitant-oral/article.htm

Consumer information about the medication APREPITANT - ORAL (Emend), includes side effects, drug interactions, recommended dosages, and storage ...

EMEND 80mg, 125mg hard Capsules - Summary of Product ...

www.medicines.org.uk/emc/medicine/13868

Apr 11, 2016 ... Each 125 mg capsule contains 125 mg of aprepitant. Each 80 mg capsule contains 80 mg of aprepitant. Excipient with known effect.

aprepitant oral : Uses, Side Effects, Interactions, Pictures, Warnings ...

www.webmd.com/drugs/2/drug-75031/aprepitant-oral/details

Find patient medical information for aprepitant oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

DrugBank: Aprepitant

www.drugbank.ca/drugs/DB00673

Jun 13, 2005 ... Aprepitant is metabolized primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19. Seven metabolites of aprepitant, which are ...

Aprepitant: a review of its use in the prevention of chemotherapy ...

www.ncbi.nlm.nih.gov/pubmed/15025555

Oral aprepitant, in combination with other agents, is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) ...

Aprepitant: a neurokinin-1 receptor antagonist for the treatment of ...

www.ncbi.nlm.nih.gov/pubmed/15485308

Expert Rev Anticancer Ther. 2004 Oct;4(5):715-24. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and ...

Aprepitant: a substance P antagonist for chemotherapy ... - NCBI

www.ncbi.nlm.nih.gov/pubmed/17401221

Indian J Cancer. 2007 Jan-Mar;44(1):25-30. Aprepitant: a substance P antagonist for chemotherapy induced nausea and vomiting. Girish C(1), Manikandan S.

More Info

Aprepitant: MedlinePlus Drug Information

medlineplus.gov

Apr 15, 2016 ... Aprepitant: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Emend Capsules (Aprepitant Capsules): Side Effects, Interactions ...

www.rxlist.com

EMEND capsules contain the active ingredient, aprepitant. Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist, an antiemetic agent, chemically ...

Emend - Merck.com

www.merck.com

and effectively. See full prescribing information for EMEND. CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral use.